Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 12

Results: 19

High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1794, doi. 10.1038/sj.onc.1210798
By:
- Bottley, G.;
- Watherston, O. G.;
- Hiew, Y.-L.;
- Norrild, B.;
- Cook, G. P.;
- Blair, G. E.
Publication type:
Article
CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1705, doi. 10.1038/sj.onc.1210802
By:
- Kadaja-Saarepuu, L.;
- Laos, S.;
- Jääger, K.;
- Viil, J.;
- Balikova, A.;
- Lõoke, M.;
- Hansson, G. C.;
- Maimets, T.
Publication type:
Article
Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1665, doi. 10.1038/sj.onc.1210804
By:
- Kfoury, Y.;
- Nasr, R.;
- Favre-Bonvin, A.;
- El-Sabban, M.;
- Renault, N.;
- Giron, M.-L.;
- Setterblad, N.;
- Hajj, H. El;
- Chiari, E.;
- Mikati, A. G.;
- Hermine, O.;
- Saib, A.;
- de Thé, H.;
- Pique, C.;
- Bazarbachi, A.
Publication type:
Article
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1805, doi. 10.1038/sj.onc.1210805
By:
- Cooper, W. N.;
- Dickinson, R. E.;
- Dallol, A.;
- Grigorieva, E. V.;
- Pavlova, T. V.;
- Hesson, L. B.;
- Bieche, I.;
- Broggini, M.;
- Maher, E. R.;
- Zabarovsky, E. R.;
- Clark, G. J.;
- Latif, F.
Publication type:
Article
Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1716, doi. 10.1038/sj.onc.1210806
By:
- Choi, D.;
- Lee, S.-J.;
- Hong, S.;
- Kim, I.-H.;
- Kang, S.
Publication type:
Article
S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1726, doi. 10.1038/sj.onc.1210807
By:
- Guirouilh-Barbat, J.;
- Huck, S.;
- Lopez, B. S.
Publication type:
Article
Interference of the dominant negative helix–loop–helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1657, doi. 10.1038/sj.onc.1210808
By:
- Hasskarl, J.;
- Mern, D. S.;
- Münger, K.
Publication type:
Article
Widespread deregulation of microRNA expression in human prostate cancer.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1788, doi. 10.1038/sj.onc.1210809
By:
- Ozen, M.;
- Creighton, C. J.;
- Ozdemir, M.;
- Ittmann, M.
Publication type:
Article
HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1800, doi. 10.1038/sj.onc.1210810
By:
- Massimi, P.;
- Shai, A.;
- Lambert, P.;
- Banks, L.
Publication type:
Article
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1749, doi. 10.1038/sj.onc.1210811
By:
- Ma, S.;
- Lee, T. K.;
- Zheng, B.-J.;
- Chan, K. W.;
- Guan, X.-Y.
Publication type:
Article
Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1687, doi. 10.1038/sj.onc.1210812
By:
- Kanda, I.;
- Nishimura, N.;
- Nakatsuji, H.;
- Yamamura, R.;
- Nakanishi, H.;
- Sasaki, T.
Publication type:
Article
FOXO transcription factor-dependent p15INK4b and p19INK4d expression.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1677, doi. 10.1038/sj.onc.1210813
By:
- Katayama, K.;
- Nakamura, A.;
- Sugimoto, Y.;
- Tsuruo, T.;
- Fujita, N.
Publication type:
Article
An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1696, doi. 10.1038/sj.onc.1210814
By:
- Park, H. J.;
- Wang, Z.;
- Costa, R. H.;
- Tyner, A.;
- Lau, L. F.;
- Raychaudhuri, P.
Publication type:
Article
Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1759, doi. 10.1038/sj.onc.1210815
By:
- Milliken, E. L.;
- Lozada, K. L.;
- Johnson, E.;
- Landis, M. D.;
- Seachrist, D. D.;
- Whitten, I.;
- Sutton, A. L. M.;
- Abdul-Karim, F. W.;
- Keri, R. A.
Publication type:
Article
Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1779, doi. 10.1038/sj.onc.1210816
By:
- Nieto-Miguel, T.;
- Gajate, C.;
- González-Camacho, F.;
- Mollinedo, F.
Publication type:
Article
Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1737, doi. 10.1038/sj.onc.1210819
By:
- Roelle, S.;
- Grosse, R.;
- Buech, T.;
- Chubanov, V.;
- Gudermann, T.
Publication type:
Article
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells.
Published in:
Oncogene, 2008, v. 27, n. 12, p. 1767, doi. 10.1038/sj.onc.1210820
By:
- Barbetti, V.;
- Gozzini, A.;
- Rovida, E.;
- Morandi, A.;
- Spinelli, E.;
- Fossati, G.;
- Mascagni, P.;
- Lübbert, M.;
- Sbarba, P. Dello;
- Santini, V.
Publication type:
Article
Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response.
Published in:
2008
By:
- Cheng1, Z.;
- Ke, Y.;
- Ding, X.;
- Wang, F.;
- Wang, H.;
- Wang, W.;
- Ahmed, K.;
- Liu, Z.;
- Xu, Y.;
- Aikhionbare, F.;
- Yan, H.;
- Liu, J.;
- Xue, Y.;
- Yu, J.;
- Powell, M.;
- Liang, S.;
- Wu, Q.;
- Reddy, S. E.;
- Hu, R.;
- Huang, H.
Publication type:
Correction Notice
Cell type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR.
Published in:
2008
By:
- Begum, S.;
- Emami, N.;
- Cheung, A.;
- Wilkins, O.;
- Der, S.;
- Hamel, P. A.
Publication type:
Correction Notice

Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 12

High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.

CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.

Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome.

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways.

S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining.

Interference of the dominant negative helix–loop–helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities.

Widespread deregulation of microRNA expression in human prostate cancer.

HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.

CD133<sup>+</sup> HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering.

FOXO transcription factor-dependent p15<sup>INK4b</sup> and p19<sup>INK4d</sup> expression.

An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.

Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.

Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.

Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells.

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells.

Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response.

Cell type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR.